is part of the Global Exhibitions Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Steven Tave is the director of the Office of Dietary Supplement Programs (ODSP) in FDA’s Center for Food Safety and Applied Nutrition. He was named ODSP’s first permanent director in November 2016 after serving as acting director beginning in March 2016. Tave was previously the acting director of the Office of Unapproved New Drugs and Labeling Compliance in FDA’s Center for Drug Evaulation and Research (CDER) Office of Compliance. There he led a multidisciplinary staff responsible for operations and regulatory actions with respect to misbranded and unapproved new drugs, including compounded drugs, fraudulent drugs, homeopathic drugs, marketed unapproved drugs and over-the-counter (OTC) drugs. Tave practiced law for almost 15 years, both as a litigator in FDA’s Office of Chief Counsel and in the private sector. He received his law degree from the University of Virginia School of Law and his bachelor’s degree from Northwestern University.
While the administration has changed, the agencies that regulate the dietary supplement industry still have their charge and are continuing to work to ensure companies are meeting their obligations and delivering safe, efficacious products to consumers. Join FDA’s Steven Tave, director of the Office of Dietary Supplement Programs, as he shares the latest insights on FDA’s activities in the dietary supplement space. This presentation is open to all SupplySide West attendees, so be sure to take advantage of the opportunity to get the latest on GMP compliance, new dietary ingredient (NDI) registration, FSMA obligations and much more.